New research reveals the molecular mechanisms that cause vascular stenosis in diabetes
-
Last Update: 2020-12-27
-
Source: Internet
-
Author: User
Search more information of high quality chemicals, good prices and reliable suppliers, visit
www.echemi.com
blood vessel stenosis is one of the main complications of diabetes and increases the risk of diseases such as heart disease and stroke. A new U.S. study says the molecular mechanisms that cause vascular stenosis caused by diabetes have been discovered, which could help develop precise diabetes-targeted drugs.
team at the University of California, Davis, has previously found that high blood sugar activates an enzyme in the body called protein kinase A, which increases calcium channel activity and constricts blood vessels.
to understand the molecular mechanisms, the team built a model of diabetic mice that focused on the relationship between protein kinase A and adenosine cyclase (AC). Adenosine cycloase is an enzyme involved in the synthesis of cyclosides, a messenger substance that is critical to the function of blood vessel cells.In a paper published in the American Journal of Clinical Examinations, the
team said the latest animal results show that AC5, a specific type of adenosine cyclase, is critical for blood vessel contractions in diabetic patients, regulating protein kinase A and cyclosideside activity, triggering increased calcium channel activity and vascular contraction."Our study raises a clearer picture of how high blood sugar damages the vascular system and provides us with a target to stop this effect," said
co-author Roger Tetrian, a professor at the University of California, Davis. As
next step, the team plans to verify the "chain reaction" of AC5 in human cells under high blood sugar conditions. (Source: Xinhua News Agency)
relevant paper information:
This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only.
This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of
the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed
description of the concern or complaint, to
service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content
will be removed immediately.